211 related articles for article (PubMed ID: 24967060)
1. Preparation and characterization of celecoxib solid dispersions; comparison of poloxamer-188 and PVP-K30 as carriers.
Homayouni A; Sadeghi F; Nokhodchi A; Varshosaz J; Garekani HA
Iran J Basic Med Sci; 2014 May; 17(5):322-31. PubMed ID: 24967060
[TBL] [Abstract][Full Text] [Related]
2. Anomalous dissolution behavior of celecoxib in PVP/Isomalt solid dispersions prepared using spray drier.
Ghanavati R; Taheri A; Homayouni A
Mater Sci Eng C Mater Biol Appl; 2017 Mar; 72():501-511. PubMed ID: 28024614
[TBL] [Abstract][Full Text] [Related]
3. Preparation and characterization of celecoxib dispersions in soluplus(®): comparison of spray drying and conventional methods.
Homayouni A; Sadeghi F; Nokhodchi A; Varshosaz J; Afrasiabi Garekani H
Iran J Pharm Res; 2015; 14(1):35-50. PubMed ID: 25561910
[TBL] [Abstract][Full Text] [Related]
4. Physicochemical characterization and in vitro dissolution studies of solid dispersions of ketoprofen with PVP K30 and d-mannitol.
Yadav PS; Kumar V; Singh UP; Bhat HR; Mazumder B
Saudi Pharm J; 2013 Jan; 21(1):77-84. PubMed ID: 24109206
[TBL] [Abstract][Full Text] [Related]
5. Physicochemical characterization and dissolution study of solid dispersions of Lovastatin with polyethylene glycol 4000 and polyvinylpyrrolidone K30.
Patel RP; Patel MM
Pharm Dev Technol; 2007; 12(1):21-33. PubMed ID: 17484141
[TBL] [Abstract][Full Text] [Related]
6. Comparing various techniques to produce micro/nanoparticles for enhancing the dissolution of celecoxib containing PVP.
Homayouni A; Sadeghi F; Varshosaz J; Garekani HA; Nokhodchi A
Eur J Pharm Biopharm; 2014 Sep; 88(1):261-74. PubMed ID: 24952357
[TBL] [Abstract][Full Text] [Related]
7. Preparation and characterization of solid dispersions of carvedilol with PVP K30.
Sharma A; Jain CP
Res Pharm Sci; 2010 Jan; 5(1):49-56. PubMed ID: 21589768
[TBL] [Abstract][Full Text] [Related]
8. Preparation, Characterization and Stability Studies of Glassy Solid Dispersions of Indomethacin using PVP and Isomalt as carriers.
Khodaverdi E; Khalili N; Zangiabadi F; Homayouni A
Iran J Basic Med Sci; 2012 May; 15(3):820-32. PubMed ID: 23493157
[TBL] [Abstract][Full Text] [Related]
9. Application of Solid Dispersion Technique to Improve Solubility and Sustain Release of Emamectin Benzoate.
Huang BB; Liu DX; Liu K; Wu G
Molecules; 2019 Nov; 24(23):. PubMed ID: 31779169
[TBL] [Abstract][Full Text] [Related]
10. Solid dispersion of carbamazepine in PVP K30 by conventional solvent evaporation and supercritical methods.
Sethia S; Squillante E
Int J Pharm; 2004 Mar; 272(1-2):1-10. PubMed ID: 15019063
[TBL] [Abstract][Full Text] [Related]
11. Preparation and characterisation of solid dispersions of tanshinone IIA, cryptotanshinone and total tanshinones.
Zhai X; Li C; Lenon GB; Xue CCL; Li W
Asian J Pharm Sci; 2017 Jan; 12(1):85-97. PubMed ID: 32104317
[TBL] [Abstract][Full Text] [Related]
12. Formulation, characterization and and evaluation of aloe-emodin-loaded solid dispersions for dissolution enhancement.
Xiuyan LI; Yuting L; Jinhui W; Zhimin DU
J Tradit Chin Med; 2024 Feb; 44(1):54-62. PubMed ID: 38213239
[TBL] [Abstract][Full Text] [Related]
13. Structural Elucidation of Poloxamer 237 and Poloxamer 237/Praziquantel Solid Dispersions: Impact of Poly(Vinylpyrrolidone) over Drug Recrystallization and Dissolution.
Orlandi S; Priotti J; Diogo HP; Leonardi D; Salomon CJ; Nunes TG
AAPS PharmSciTech; 2018 Apr; 19(3):1274-1286. PubMed ID: 29313262
[TBL] [Abstract][Full Text] [Related]
14. Preparation and Characterization of Furosemide Solid Dispersion with Enhanced Solubility and Bioavailability.
Zhang F; Mao J; Tian G; Jiang H; Jin Q
AAPS PharmSciTech; 2022 Jan; 23(1):65. PubMed ID: 35102461
[TBL] [Abstract][Full Text] [Related]
15. Development and physicochemical characterization of sirolimus solid dispersions prepared by solvent evaporation method.
Emami S; Valizadeh H; Islambulchilar Z; Zakeri-Milani P
Adv Pharm Bull; 2014 Dec; 4(4):369-74. PubMed ID: 25436193
[TBL] [Abstract][Full Text] [Related]
16. In vitro and in vivo studies on a novel solid dispersion of repaglinide using polyvinylpyrrolidone as the carrier.
Yin LF; Huang SJ; Zhu CL; Zhang SH; Zhang Q; Chen XJ; Liu QW
Drug Dev Ind Pharm; 2012 Nov; 38(11):1371-80. PubMed ID: 22296267
[TBL] [Abstract][Full Text] [Related]
17. Preparation and characterization of cefuroxime axetil solid dispersions using hydrophilic carriers.
Gorajana A; Rajendran A; Yew LM; Dua K
Int J Pharm Investig; 2015; 5(3):171-8. PubMed ID: 26258059
[TBL] [Abstract][Full Text] [Related]
18. Enhancement of the dissolution profile of allopurinol by a solid dispersion technique.
Samy AM; Marzouk MA; Ammar AA; Ahmed MK
Drug Discov Ther; 2010 Apr; 4(2):77-84. PubMed ID: 22491164
[TBL] [Abstract][Full Text] [Related]
19. Formulation development and dissolution rate enhancement of efavirenz by solid dispersion systems.
Koh PT; Chuah JN; Talekar M; Gorajana A; Garg S
Indian J Pharm Sci; 2013 May; 75(3):291-301. PubMed ID: 24082345
[TBL] [Abstract][Full Text] [Related]
20. Preparation, optimisation, and in vitro-in vivo evaluation of febuxostat ternary solid dispersion.
Tang J; Bao J; Shi X; Sheng X; Su W
J Microencapsul; 2018 Aug; 35(5):454-466. PubMed ID: 30229692
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
